Accumulated studies have demonstrated that the activation of β-catenin (CTNNB1) is associated with angiogenesis and cancer metastasis by modulating the expression of VEGF and the matrix metalloproteinases (MMPs) pathway in CRC [40,41]. The gene discussed is CTNNB1; the disease is cancer.